Samar Singh, M.D.

Samar Singh, M.D., grew up in a family full of physicians. Inspired both by their passion for their career paths and the difference she saw them make in the community, she continued the tradition, ultimately choosing endocrinology as her specialty.

Dr. Singh treasures her interactions with patients and works diligently to relieve the burdens of chronic metabolic disease with a treatment approach based in shared decision-making. She puts listening first, and she makes certain to explain medical concepts to patients in a way that they can understand.

For her medical training, Dr. Singh went to East Carolina University’s Brody School of Medicine. Her residency in internal medicine and fellowship in endocrinology took place at the University of California, Irvine, where she served as chief resident and was honored as fellow of the year.

Prior to City of Hope, Dr. Singh was associate clinical professor and program director in the Department of Endocrinology at UC Irvine, which named her a top 20 doctor for achieving outstanding results in patient communications. She has also been recognized as a Southern California Top Doctors Rising Star.

Dr. Singh, who is fluent in Punjabi, enjoys spending her free time with her family.

• Chahal R, Shah P, Singh S, Rosenblit P. Connecting Dots: Hypoglycemia, Cardiovascular Outcomes, and All-Cause Mortality. http://www.acc.org. Mar 26, 2020. https://www.acc.org/latest-in-cardiology/articles/2020/03/25/13/03/connecting-dots.
• Sheu I, Choi Y, Singh S, Wang P. Maturity-Onset Diabetes of the Young (MODY)-4 Presenting as Gestational Diabetes. Diabetes in Practice. Case 2. 2021.
• Singh S, Bhat J, Wang P. Cardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus. Current Cardiology Reports. 2013. 15:327.
• Ahern S, Nguyen H, Lyou Y, Singh S, Wang P. Case 56: Type B Insulin Resistance Syndrome. Atypical Diabetes: Pathophysiology, Clinical Presentations, and Treatment Options. 2017